Home | Non-food | Drug | Artificial Pancreas Aids Type 1 Diabetes Patients

Artificial Pancreas Aids Type 1 Diabetes Patients

Font size: Decrease font Enlarge font

One problem facing type 1 diabetics is hypoglycemia; a condition in which blood sugar drops to dangerously low levels after the use of insulin.
 
Researchers at the University of Cambridge have developed a device that can simultaneously monitor and automatically pump an appropriate amount of insulin into the blood stream overnight in patients, according to a report published on Friday in the British medical journal Lancet.
 
Type 1 diabetics must use insulin; however, it is difficult for patients to know the exact dosage they need.  When too much of insulin is used, blood sugar drops quickly, potentially leading to hypoglycemia.
 
The device, which has been referred to as an artificial pancreas, can calculate the appropriate amount of insulin to deliver based on real time blood sugar readings.
 
Dr Roman Hovorka and colleagues of the Institute of Metabolic Science at the University tested the artificial pancreas in 17 children and teenagers between the ages 5 and 18 with type 1 diabetes. The children were monitored for 54 nights in a hospital to determine how well the system could measure controlled glucose levels compared to the children's regular continuous subcutaneous insulin infusion pump.
 
The researchers tested the system on nights when the subjects went to bed after eating a large dinner or after having participated in early evening or late afternoon exercise - both of which would raise risk of hypoglycemia.
 
The artificial pancreas kept blood sugar levels normal for 60 percent of the time, compared to 40 percent for the conventional insulin pump.
 
Additionally, the artificial pancreas cut by half the time that blood sugar fell below 3.9 mmol/L- a level defined as mild hypoglycemia.
 
The artificial pancreas did not cause blood sugar to fall below 3.0 mmol/L, which is defined as significant hypoglycemia while the conventional insulin pump resulted in nine hypoglycemia events during the study.
 
Dr. Hovorka said "Our results show that commercially-available devices, when coupled with the algorithm we developed, can improve glucose control in children and significantly reduce the risk of hypos overnight."
 
Common symptoms of hypoglycemia include hunger, shakiness, nervousness, sweating, dizziness, sleepiness, confusion, difficulty speaking, anxiety and weakness, according to a publication by the National Diabetes Information Clearinghouse.
 
People with diabetes need to know the signs and symptoms; should any show up, they need to take measures to correct the condition.

David Liu and editing by Rachel Stockton

Subscribe to comments feed Comments (5 posted):

Jon Lindenberg on 08/02/2010 00:17:29
avatar
Paragraph 6 states that evening exercise AND a heavy evening meal can lead to hypoglycemia. Exercise can, but a large meal has the OPPOSITE effect. Check your facts please. I've been type 1 for 54 years and NEVER has eating too much led to low blood sugar levels.
Thumbs Up Thumbs Down
0
John Tkach on 08/02/2010 01:00:52
avatar
I agree with Jon Lindenberg. I've only been a Type 1 diabetic for 32 years. I thought everybody knew that to counteract hypoglycemia, you eat. Most notably, orange juice is the most popular method.
Thumbs Up Thumbs Down
0
RG on 08/02/2010 01:11:12
avatar
15 years and never been hypoglycemic beacuse of eating. however, the author probably referred to the fact that after eating a large meal, one tends to dose up Insuline and this might tend to increase the chances of low sugar levels overnight. Certainly requires a bit more info to complete the article so that it reads correctly
Thumbs Up Thumbs Down
0
happy on 08/02/2010 01:21:59
avatar
A good article, artificial pancreas sounds like a great idea for some who are missing it.
Thumbs Up Thumbs Down
0
Michael J Curtin MD on 08/02/2010 01:24:11
avatar
Jon and John are, of course both correct, but I expect that theirs are editorial corrections. The real question, in my mind, and I am a Type I for over 47 years and have only the stigamata of retinal disease fully corrected, believe that the issues havemore to do with the price one would pay for the reported results, i.e. cost, liability to infections, specificity of results over time, mechanics of maintnance, etc. Once you have this disease and survive for an unexpected time the alternatives for management may be not worth the effort and potential complications. Further, compulsive continual management may be the unpleasant but more effective management. It also seems to me that DM I is not a single disease and that the variants may be identifiable and require several different plans for mangement.
Thumbs Up Thumbs Down
0

Post your comment comment

Please enter the code you see in the image:

  • email Email to a friend
  • print Print version
  • Plain text Plain text
Newsletter
Email:
Tags

Rate this article
0